查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1728187

非處方止痛藥市場－全球產業規模、佔有率、趨勢、機會和預測（按藥品類型、配銷通路、地區和競爭細分，2020-2030 年）

Over-the-Counter Analgesics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Distribution Channel, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球非處方 (OTC) 止痛藥市場價值為 210.5 億美元，預計到 2030 年將達到 351.2 億美元，預測期內複合年成長率為 8.91%。這種成長主要歸因於消費者對自我藥療的偏好不斷增加、對疼痛管理的認知不斷提高以及易患慢性疼痛疾病的老年人口不斷擴大。非處方止痛藥因其易於取得、成本效益高和方便性而被廣泛使用。此外，與生活方式相關的疾病和體力活動相關傷害的增加也推動了對緩解疼痛的解決方案的需求。隨著人們意識的增強和對安全使用非處方藥的監管支持的擴大，市場有望在全球範圍內繼續發展。

市場概覽
預測期 2026-2030
2024年市場規模 210.5億美元
2030年市場規模 351.2億美元
2025-2030 年複合年成長率 8.91%
成長最快的領域 網路藥局
最大的市場 北美洲

關鍵市場促進因素

人口老化和慢性病加劇

主要市場挑戰

監管審查和安全問題

主要市場趨勢

個人化疼痛緩解方案

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球非處方（OTC）止痛藥市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依藥物類型（對乙醯氨基酚、非類固​​醇抗發炎藥 (NSAID)、水楊酸鹽和其他鎮痛藥）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按地區（北美、歐洲、亞太、南美、中東和非洲）
    • 按公司分類（2024）
  • 市場地圖
    • 依藥物類型
    • 按配銷通路
    • 按地區

第6章：北美非處方（OTC）止痛藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲非處方（OTC）止痛藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太非處方（OTC）止痛藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美非處方（OTC）止痛藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲非處方 (OTC) 鎮痛藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球非處方（OTC）止痛藥市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc
  • GSK plc
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca Plc
  • Merck & Co Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 17073

The Global Over-the-Counter (OTC) Analgesics Market was valued at USD 21.05 billion in 2024 and is projected to reach USD 35.12 billion by 2030, growing at a CAGR of 8.91% during the forecast period. This growth is primarily attributed to increasing consumer preference for self-medication, rising awareness about pain management, and expanding geriatric population susceptible to chronic pain conditions. OTC analgesics are widely used due to their ease of availability, cost-effectiveness, and convenience. Moreover, lifestyle-related disorders and an increase in physical activity-related injuries are boosting the demand for pain relief solutions. As awareness grows and regulatory support for safe OTC use expands, the market is poised for continued advancement across global regions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 21.05 Billion
Market Size 2030USD 35.12 Billion
CAGR 2025-20308.91%
Fastest Growing SegmentOnline Pharmacies
Largest MarketNorth America

Key Market Drivers

Rising Aging Population and Chronic Conditions

The increasing elderly population and growing prevalence of chronic health issues are key contributors to the demand for OTC analgesics. Older adults often manage long-term conditions that cause recurring pain, leading to a consistent reliance on easily accessible medications. Many prefer OTC options over prescription drugs due to their convenience, affordability, and fewer regulatory hurdles. These conditions, including arthritis and back pain, span across age groups, expanding the target consumer base. Additionally, rising public awareness about chronic pain management encourages consumers to opt for OTC solutions that offer effective and quick relief without requiring a doctor's consultation.

Key Market Challenges

Regulatory Scrutiny and Safety Concerns

Strict regulatory oversight and ongoing safety evaluations present significant challenges for the OTC analgesics market. Authorities enforce stringent rules on ingredients, dosages, and interactions to ensure public safety, and any identified risks can lead to restrictions or product withdrawals. Adverse event reports or product recalls can harm brand trust and slow market momentum. Warning labels, age restrictions, and contraindications further narrow the target audience. These factors collectively create a cautious consumer environment, potentially curbing product usage and inhibiting market expansion.

Key Market Trends

Personalized Pain Relief Solutions

The demand for personalized OTC analgesics is gaining traction as consumers seek products tailored to their specific pain types, such as migraines or joint pain. This customization aligns with modern consumer expectations and improves user satisfaction and loyalty. By diversifying product offerings to address a broader range of conditions, companies can reach varied consumer segments. Innovation in formulation and delivery mechanisms not only sets brands apart but also drives sustained growth. Personalized solutions often lead to stronger consumer retention, reinforcing market strength through repeat purchases and brand advocacy.

Key Market Players

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc
  • GSK plc
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca PLC
  • Merck & Co Inc.

Report Scope:

In this report, the Global Over-the-Counter (OTC) Analgesics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Over-the-Counter (OTC) Analgesics Market, By Drug Type:

  • Acetaminophen
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Salicylates
  • Other Analgesics

Over-the-Counter (OTC) Analgesics Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Over-the-Counter (OTC) Analgesics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Over-the-Counter (OTC) Analgesics Market.

Available Customizations:

Global Over-the-Counter (OTC) Analgesics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Over-the-Counter (OTC) Analgesics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
    • 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Drug Type
    • 5.3.2. By Distribution Channel
    • 5.3.3. By Region

6. North America Over-the-Counter (OTC) Analgesics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Type
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Type
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Type
        • 6.3.3.2.2. By Distribution Channel

7. Europe Over-the-Counter (OTC) Analgesics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. Germany Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Type
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Type
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Type
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Type
        • 8.3.5.2.2. By Distribution Channel

9. South America Over-the-Counter (OTC) Analgesics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Over-the-Counter (OTC) Analgesics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Over-the-Counter (OTC) Analgesics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Bayer AG
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Boehringer Ingelheim International GmbH
  • 15.3. Johnson & Johnson Services Inc
  • 15.4. GSK plc
  • 15.5. Pfizer Inc.
  • 15.6. Sanofi SA
  • 15.7. Sun Pharmaceutical Industries Ltd.
  • 15.8. Takeda Pharmaceutical Company Limited
  • 15.9. AstraZeneca Plc
  • 15.10. Merck & Co Inc.

16. Strategic Recommendations

17. About Us & Disclaimer